1. Home
  2. NSYS vs ALXO Comparison

NSYS vs ALXO Comparison

Compare NSYS & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSYS
  • ALXO
  • Stock Information
  • Founded
  • NSYS 1981
  • ALXO 2015
  • Country
  • NSYS United States
  • ALXO United States
  • Employees
  • NSYS N/A
  • ALXO N/A
  • Industry
  • NSYS Industrial Machinery/Components
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NSYS Technology
  • ALXO Health Care
  • Exchange
  • NSYS Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • NSYS 22.3M
  • ALXO 58.9M
  • IPO Year
  • NSYS N/A
  • ALXO 2020
  • Fundamental
  • Price
  • NSYS $9.06
  • ALXO $1.17
  • Analyst Decision
  • NSYS
  • ALXO Strong Buy
  • Analyst Count
  • NSYS 0
  • ALXO 6
  • Target Price
  • NSYS N/A
  • ALXO $3.30
  • AVG Volume (30 Days)
  • NSYS 5.2K
  • ALXO 1.7M
  • Earning Date
  • NSYS 08-07-2025
  • ALXO 08-12-2025
  • Dividend Yield
  • NSYS N/A
  • ALXO N/A
  • EPS Growth
  • NSYS N/A
  • ALXO N/A
  • EPS
  • NSYS N/A
  • ALXO N/A
  • Revenue
  • NSYS $117,597,000.00
  • ALXO N/A
  • Revenue This Year
  • NSYS N/A
  • ALXO N/A
  • Revenue Next Year
  • NSYS N/A
  • ALXO N/A
  • P/E Ratio
  • NSYS N/A
  • ALXO N/A
  • Revenue Growth
  • NSYS N/A
  • ALXO N/A
  • 52 Week Low
  • NSYS $7.25
  • ALXO $0.40
  • 52 Week High
  • NSYS $13.90
  • ALXO $2.42
  • Technical
  • Relative Strength Index (RSI)
  • NSYS 56.89
  • ALXO 69.75
  • Support Level
  • NSYS $8.05
  • ALXO $1.05
  • Resistance Level
  • NSYS $9.74
  • ALXO $1.22
  • Average True Range (ATR)
  • NSYS 0.24
  • ALXO 0.13
  • MACD
  • NSYS 0.08
  • ALXO 0.03
  • Stochastic Oscillator
  • NSYS 42.86
  • ALXO 87.67

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: